Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
L.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.518ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15159.2France
B.1.518ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.518ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.518NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.551ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.551ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.551ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.551NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.17ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.17ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.17ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.17NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.207ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.207ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.207ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.207NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.604ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.604ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.604ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.604NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.111ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.111ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.111ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.111NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.619ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.619ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.619ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.619NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.36.3.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.36.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.3.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
C.36.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
C.36.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
C.36.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
C.36.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.23.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-15125.9France
A.23.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.23.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.23.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.316ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.316ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.316ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.316NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AZ.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used